| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/02/1997 | EP0674511B1 Antipyretic and analgesic compositions containing optically pure r-ketorolac |
| 04/02/1997 | EP0670735B1 Peripheralization of hematopoietic stem cells |
| 04/02/1997 | EP0668853B1 Succinic acid derivatives for use as skin conditioners |
| 04/02/1997 | EP0659172B1 Analogues of vpa used as anti-epileptica |
| 04/02/1997 | EP0656773B1 Use of radical catchers as immunomodulating agents in cosmetic and dermatological compositions |
| 04/02/1997 | EP0637958B1 Anti-obesity drugs |
| 04/02/1997 | EP0634400B1 Pyridinecarboximidamide compound and use thereof |
| 04/02/1997 | EP0623127B1 Novel neurotransmitter releasers useful for cognition enhancement |
| 04/02/1997 | EP0622076B1 Inhibitor for restenosis after percutaneous coronary arterioplasty |
| 04/02/1997 | EP0587625B1 N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1,4-benzodioxine and the process of preparation thereof |
| 04/02/1997 | EP0573465B1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 04/02/1997 | EP0507851B1 Quinolone carboxylic acid--metal ion--acid complexes |
| 04/02/1997 | CN1146769A Method for stabilizing compound DX-52-1 and lyophilized composition thereof |
| 04/02/1997 | CN1146768A Process for making an epoxide |
| 04/02/1997 | CN1146765A Use of imidazole derivatives for treating disorders involving angiotensin receptors AT 1 and AT2, certain such products preparation thereof, use thereof as drugs, and pharmaceutical composition contai |
| 04/02/1997 | CN1146725A Gel for treatment of skin diseases and for disinfection of the skin |
| 04/02/1997 | CN1146722A Taxane class derivative based pharmaceutical compositions |
| 04/02/1997 | CN1146720A New pharmaceutical formulation and preparation process |
| 04/02/1997 | CN1146337A Anti-parasite oral liquid for animal containing avermectin or ivermectin |
| 04/02/1997 | CN1034415C Method for prepn. of novel ascorbic acid derivatives |
| 04/02/1997 | CN1034391C Preparation for intravaginal devices |
| 04/01/1997 | US5616759 Cyclohexylidene compounds |
| 04/01/1997 | US5616741 Process for the preparation of glycine-conjugated bile acids |
| 04/01/1997 | US5616740 Process for making 9-deoxotaxane compounds |
| 04/01/1997 | US5616739 Method of preparing taxane derivatives |
| 04/01/1997 | US5616738 A 7-carboxybenzofuran intermediate for drugs having gastrointestinal motility stimulating properties |
| 04/01/1997 | US5616724 Fused pyrrolo[2,3-c]carbazole-6-ones |
| 04/01/1997 | US5616722 Antimicrobial solution of formaldehyde substituted hydantoin and process for preparation |
| 04/01/1997 | US5616720 Treating 1,6-diphenyl- or dihetero-substituted 2,5-diaminohexanol/3-/ with tetraalkoxytitanium, then amidation of reaction product and acylation yield stable viricides |
| 04/01/1997 | US5616716 (3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds |
| 04/01/1997 | US5616712 Skin disorders; anticarcinogenic and -inflammatory agents; autoimmune diseases; |
| 04/01/1997 | US5616709 Method of synthesis for 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its dimaleate salt |
| 04/01/1997 | US5616707 N-methyl-4-pyridyl-3-but(ene or yne)-1-amine |
| 04/01/1997 | US5616705 Useful in the control of diseases |
| 04/01/1997 | US5616703 Separation of cephalosporin isomers |
| 04/01/1997 | US5616620 Amino acid derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of obesity |
| 04/01/1997 | US5616619 Topical composition for burn relief and method of use |
| 04/01/1997 | US5616618 Administering to treat chronic pain |
| 04/01/1997 | US5616617 Face pimples prevention method and compositions |
| 04/01/1997 | US5616614 Useful in treatment of disorders linked to abnormal melatonin activity |
| 04/01/1997 | US5616612 Therapy for cancer, aids, anemia, infections |
| 04/01/1997 | US5616611 Stabilizer, antioxidant |
| 04/01/1997 | US5616610 Central nervous system disorders |
| 04/01/1997 | US5616608 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 04/01/1997 | US5616606 Distamycin derivatives; deactivation of nucleic acids by binding with no steric hindrance problems; hiv and hepatitus virus |
| 04/01/1997 | US5616603 Treating migraines |
| 04/01/1997 | US5616602 Skin disorders |
| 04/01/1997 | US5616601 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation |
| 04/01/1997 | US5616596 Substituted arylalkynyl-and heteroarylalkynl-N-hydroxyurea inhibitors of leukotriene biosynthesis |
| 04/01/1997 | US5616593 Compositions containing piperine |
| 04/01/1997 | US5616592 Useful for disorders of cardiovascular, gastrointestinal and psychological disorders |
| 04/01/1997 | US5616589 Bis-naphthalimides for the treatment of cancer |
| 04/01/1997 | US5616588 Rapamycin formulation for IV injection |
| 04/01/1997 | US5616587 Aqueous risperidone formulations |
| 04/01/1997 | US5616586 Tricyclic quinoxalinediones |
| 04/01/1997 | US5616585 Pyridopyrazine derivatives for treating alcohol and nicotine abuse and addiction |
| 04/01/1997 | US5616584 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
| 04/01/1997 | US5616583 N- (3-hydroxy-4-piperidinyl) (benzodioxolane, benzodioxane or benzodioxepane) carboxamide derivatives |
| 04/01/1997 | US5616582 Use as anticancer agents; e.g. gefitinib |
| 04/01/1997 | US5616580 Pharmacological composition for preventing neurotoxic side effects of NMDA antagonists |
| 04/01/1997 | US5616579 Administering to mammals to prevent gastric ulcer |
| 04/01/1997 | US5616577 Protein Kinase C inhibitor |
| 04/01/1997 | US5616576 Controlling bone resorption with pyrroloquinoline quinone (PQQ) and related compounds |
| 04/01/1997 | US5616575 Bioactive tricyclic ibogaine analogs |
| 04/01/1997 | US5616574 Steroid sulphatase inhibitors |
| 04/01/1997 | US5616573 Glucocorticoids |
| 04/01/1997 | US5616572 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
| 04/01/1997 | US5616571 Aftertreatment for side effect reduction |
| 04/01/1997 | US5616570 Inhibiting pancreatic cholesterol esterase and triglyceride lipase |
| 04/01/1997 | US5616567 2'-Cyano pyrimidine nucleoside compounds |
| 04/01/1997 | US5616566 Contacting the hiv reverse transcriptase within that cell with 2',3'-dideoxyadenosine-5'-triphosphate |
| 04/01/1997 | US5616564 Antiparasitic oligonucleotides active against drug resistant malaria |
| 04/01/1997 | US5616560 Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
| 04/01/1997 | US5616458 Tripterygium wilfordii hook F extracts and components, and uses thereof |
| 04/01/1997 | US5616345 Pelletizing the powder drug for sustained release |
| 04/01/1997 | US5616342 Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof |
| 04/01/1997 | US5616335 Mixture of organic peroxy acid, copolymeric ethylene oxide-propylene oxide thickener and isocyanate, for applying to human or animal skins or mucous membranes |
| 04/01/1997 | US5616330 Taxine, a triglyceride, water and a surfactant; anticarcinogenic agent |
| 04/01/1997 | US5616324 Pro-inflammatory composition comprising at least two members of the group consisting of DL. phenylalanine, ruta graveolans and corydalis bulbosda |
| 04/01/1997 | US5616315 Particles including degradable material and anti-microbial agent |
| 04/01/1997 | US5616313 Method for treating gingival and periodontal tissues |
| 04/01/1997 | US5616123 Delivery of solid drug compositions |
| 04/01/1997 | CA2042426C Dietary fiber, its process and physiologically active composition containing the same as an active ingredient |
| 04/01/1997 | CA2026030C Maltodextrin/defoaming composition combinate |
| 04/01/1997 | CA1339031C Method of preserving ophthalmic solutions and compositions therefor |
| 03/30/1997 | CA2186716A1 Hydroxypyridinones |
| 03/30/1997 | CA2186650A1 13-substituted milbemycin 5-oxime derivatives, their preparation and their use against insects and others pests |
| 03/30/1997 | CA2186561A1 Heterocyclic aryl-, alkyl and cycloalkylacetamides |
| 03/29/1997 | CA2186717A1 Substituted quinoline-2-carboxylic acid amides, their preparation and their use as medicaments and intermediate products |
| 03/29/1997 | CA2186709A1 Sustained-release preparation |
| 03/28/1997 | CA2186580A1 Substituted benzoylguanidines, a process for their preparation, their use as medicament or diagnostic agent, and medicament comprising them |
| 03/27/1997 | WO1997011366A1 Histone deacetylase as target for antiprotozoal agents |
| 03/27/1997 | WO1997011192A1 Dna encoding medicinal proteins |
| 03/27/1997 | WO1997011190A2 Dna construct comprising a muscle specific regulatory element for immunization or gene therapy |
| 03/27/1997 | WO1997011178A1 Human growth hormone variants |
| 03/27/1997 | WO1997011171A1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 03/27/1997 | WO1997011163A1 Pskh-1 ribozymes and uses in disease treatment |
| 03/27/1997 | WO1997011096A1 Anti-inflammatory agent |
| 03/27/1997 | WO1997011093A2 Parainfluenza virus glycoproteins and vaccines |
| 03/27/1997 | WO1997011090A1 Inhibition of tumor growth |